Union MidCap Fund
The Scheme seeks to achieve long term capital appreciation and generate income by investing predominantly in equity and equity related securities of mid cap companies.
Growthvine rating: 2/5 — ranked #21 of 33 in category.
Fund basics
| Category | Equity: Mid Cap |
|---|
| NAV | ₹53.64 (as of 2026-08-21) |
|---|
| AUM | ₹1,847 Cr |
|---|
| Expense ratio | 1.77% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Gaurav Chopra |
|---|
| Exit load | 1% for redemption within 15 days |
|---|
Performance & risk
| 5-year annualised return | 15.12% |
|---|
| Sharpe ratio | 0.66 |
|---|
| Standard deviation | 17.09% |
|---|
| Max drawdown | -21.72% |
|---|
| Alpha | -0.13 |
|---|
| Beta | 0.92 |
|---|
Over 5 years, captured 88.2% of NIFTY Midcap 150's upside and 93.5% of its downside.
Market cap allocation
| Large cap | 15.2% |
|---|
| Mid cap | 69.0% |
|---|
| Small cap | 15.8% |
|---|
Concentration
| Top 5 holdings | 14.2% |
|---|
| Top 10 holdings | 24.4% |
|---|
| Total holdings | 73 |
|---|
| Index overlap | 38.0% |
|---|
| Active share | 62.0% |
|---|
Top holdings
- Federal Bank Ltd. — 3.7%
- Max Financial Services Limited — 2.8%
- Fortis Healthcare Ltd — 2.7%
- One 97 Communications Limited — 2.5%
- NIPPON LIFE INDIA ASSET MANAGEMENT LIMITED — 2.5%
- Ipca Laboratories Ltd. — 2.2%
- Bharat Heavy Electricals Ltd. — 2.1%
- The Phoenix Mills Ltd. — 2.0%
- COFORGE LIMITED — 2.0%
- Ajanta Pharma Ltd. — 1.9%
Top sectors
- Banking & Financial — 15.6%
- Automobile — 11.2%
- Industrial Products — 9.2%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 10.3% | Q1 (Top) | #7 of 31 |
| 2025 | 2.3% | Q2 | #14 of 29 |
| 2024 | 28.6% | Q3 | #16 of 29 |
| 2023 | 32.2% | Q4 (Bottom) | #23 of 28 |
| 2022 | -2.3% | Q4 (Bottom) | #19 of 22 |